期刊文献+

老年发病系统性红斑狼疮患者临床特点分析 被引量:3

Analysis on clinical features of elderly-onset systemic lupus erythematosus
原文传递
导出
摘要 目的回顾性分析老年发病系统性红斑狼疮(SLE)住院患者的临床特征。方法由各参研单位根据统一方式收集病历资料,总结江苏省1999--2009年间916例初诊住院SLE患者的临床资料,根据发病年龄分为老年组(年龄≥60岁)及对照组(年龄〈60岁),分析不同年龄SLE患者临床表现、免疫学指标及疾病活动之间的关系。结果纳入研究范围的916例SLE患者中,老年组24例,对照组892例。老年组男性占比例、病死率较高,并发症多;盘状红斑、血小板减少、C反应蛋白(CRP)增高、血清白蛋白异常均较对照组多见(P〈0.05);而颊部红斑、光过敏较对照组少见;抗核抗体阳性率、抗Sm抗体阳性率较对照组低(P〈0.05);疾病确诊时间、发病至死亡平均年限、阳性家族史、口腔溃疡、关节炎、浆膜腔积液、神经精神系统、肌肉骨骼系统、肾脏受累、白细胞减少、贫血、血清肌酐异常、尿蛋白异常、红细胞沉降率(ESR)、抗dsDNA抗体阳性率、低补体C3、人院SLEDAI评分方面比较,两组差异无统计学意义。结论老年发病SLE患者与早发病SLE患者临床表现存在多种差异,病死率高,须提高警惕。 Objective To retrospectively analyze the clinical features of elderly-onset systemic lupus erythematosus (SIZE). Methods A total of 916 patients were enrolled in this retrospective study, and their clinical data were collected by the same methods in the past ten years (1999-2009) in fifteen hospitals in Jiangsu Province. Patients were divided into two groups based on the age of onset disease: control group and elderly group. The relationships between clinical features, immunology index and disease activity were analyzed in different age group. Results Among 916 SIzE patients, 24 patients were selected in the elderly onset SLE group, and 892 patients were considered as the control group. The ratio of male/female, mortality rate, the number of complications were higher in elderly onset SI.E group than those in the control group (all P〈 0.05), and discoid rash, thrombocytopenia, elevated C-reactive protein (CRP) level, abnormality of serum albumin were found more common in elderly onset SLE group than in control group (all P〈0.05). The incidences of Malar rash and photosensitivity, antinuclear antibodies (ANA) positivity rate, anti-Sm antibodies positivity rate were lower in elderly onset SLE group than in control group (all P〈0.05). The time of final diagnosis, mean time of onset to death, positive family history, oral ulcers, arthritis, serositis, nervous involvement, musculoskeletal disorder, renal involvement, elevated serum creatinine (Scr) level, leucopenia, hemolytic anemia, elevated proteinurine, Erythrocyte Sedimentation Rate (ESR) levels, anti dsDNA antibodies positivity rate, decreased complement C3 level, SLEDAI score had no significant differences between the two groups. Conclusions There were many differences in the clinical features between the elderly onset SLE patients and the controls, and the mortality rate is higher in the elderly onset SLE patients, which should be pay more attention to in clinical medcine.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2015年第9期996-999,共4页 Chinese Journal of Geriatrics
关键词 红斑狼疮 系统性 Lupus erythematosus, systemic
  • 相关文献

参考文献14

  • 1Arnaud L. Mathian A. BoddaertJ. et al. Late-onset systemic lupus erythematosus epidemiology, diagnosis and treatment[J]. Drugs Aging, 2012, 29: 181-189.
  • 2Yamaji K, Yasuda M, Yang KS, et al. A case of very-late-onset systemic lupus erythematosus[J] . Mod Rheumatol. 2007. 17: 441-444.
  • 3RovenskyJ, Tuchynovd A. Systemic lupus erythematosus in the elderly[J]. Autoimmun Rev, 2008,7: 235-239.
  • 4Jeleniewicz R, Suszek 0, Majdan M. Clinical picture of late-onset systemic lupus erythematosus in a group of Polish patients[J]. Pol Arch Med Wewn, 2015, 125: 538-544.
  • 5Aleksandra TL, Radmila P, Marija RP, et al. Late- onset systemic lupus erythematosus: clinical features, course, and prognosis[J]. Clin Rheumatoi , 2013,32:1053-1058.
  • 6Walker SE. Estrogen and autoimmune disease[J]. Clin Rev Allergy Immunol , 2011, 40: 60-65.
  • 7Feng X, Zou Y, Pan W, et al. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus[J]. Lupus, 2014, 23:327-334.
  • 8Achour A, Mankai A, Thabet Y, et al. Systemic lupus erythematosus in the elderly[J]. Rheumatol Int . 2012, 32:1225-1229.
  • 9Zheng T, Dongmei C, Shengmei Y, et al. Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients[J]. Rheumatol Int , 2011, 31: 1625-1629.
  • 10Cartella S, Cavazzana I, Ceribelli A, et al. Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus[J] Autoimmunity, 2013, 46: 363-368.

二级参考文献15

  • 1肖玉兰.老年系统性红斑狼疮[J].风湿病学杂志,1997,2:47-47.
  • 2Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725.
  • 3Bombardier C, Gland DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum, 1992, 35: 630-640.
  • 4施桂英 蔡醒华 丁玉珍.血清C—反应蛋白测定的临床应用[J].中华内科杂志,1984,23:491-494.
  • 5Du Clos TW. C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum, 2003, 48: 1475-1477.
  • 6Mold C, Baca R, Du Clos TW. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through FcγRs. J Autoimmun, 2002, 19: 147-154.
  • 7Gershov D, Kim S, Brot N, et al. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity. J Exp Med, 2000, 192: 1353-1364.
  • 8Christopher S, Anders AB, Gunnar S, et al. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Research & Therapy, 2004, 6:87-94 .
  • 9Liou LB. Different monocyte reaction patterns in newly diagnosed,untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels. Clin Exp Rheumatol, 2003,21: 437- 444.
  • 10:47.2.Bombardier C, Gladman DD, Vrowitz MB, et al.Derivation of the SLEDAI : a disease activity index for lupus patients. Arthritis Rheum, 1992,35:630-640.

共引文献42

同被引文献7

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部